| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific &Med Officer
1 company
Kennedy Giulia C serves as a Chief Scientific &Med Officer at VCYT. Across recent SEC filings that breaks down to 0 buys and 53 sells. Those positions are worth an estimated $1.8M at current prices.
Historically, Kennedy Giulia C's trades have earned a strong insider score of 78/100 across 11 rated trades. Over a 12-month horizon, 90.9% of those trades were profitable, with an average 12-month return of +28.8%.
The biggest single holding is VCYT (~$1.8M) as Chief Scientific &Med Officer. The recent filings there lean toward selling, a net 379,362 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2019 | VCYT Veracyte, Inc. | Chief Scientific &Med Officer | Sale+OE | 15,327 | $25.32 | $388,114.16 | -24.4% | |
| Aug 13, 2019 | VCYT Veracyte, Inc. | Chief Scientific &Med Officer | Sale+OE | 32,897 | $25.39 | $835,182.84 | -40.6% | |
| Mar 4, 2019 | VCYT Veracyte, Inc. | Chief Scientific &Med Officer | Sale+OE | 17,625 | $20.24 | $356,708.85 | -26.6% | |
| Feb 28, 2019 | VCYT Veracyte, Inc. | Chief Scientific &Med Officer | Sale+OE | 37,375 | $20.45 | $764,204.35 | -43.1% |